Tumour marker concentration at the start of chemotherapy is a stronger predictor of treatment failure than marker half-life: a study in patients with disseminated non-seminomatous testicular cancer
de Wit, R, Sylvester, R, Tsitsa, C, de Mulder, PHM, Sleyfer, DT, ten Bokkel Huinink, WW, Kaye, SB, van Oosterom, AT, Boven, E, Vermeylen, K, Stoter, GVolume:
75
Language:
english
Journal:
British Journal of Cancer
DOI:
10.1038/bjc.1997.71
Date:
February, 1997
File:
PDF, 694 KB
english, 1997